Detalhe da pesquisa
1.
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry).
Lupus
; 29(1): 27-36, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31801040
2.
IL-6 blockade reverses the abnormal STAT activation of peripheral blood leukocytes from rheumatoid arthritis patients.
Clin Immunol
; 158(2): 174-82, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25847223
3.
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review.
Eur J Intern Med
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599922
4.
Immunoglobulins in systemic sclerosis management. A large multicenter experience.
Autoimmun Rev
; 22(11): 103441, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708984
5.
The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis.
Genes Immun
; 13(2): 191-6, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22012429
6.
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis.
Ann Rheum Dis
; 70(3): 454-62, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21131644
7.
Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease.
Semin Arthritis Rheum
; 50(4): 776-790, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32534273